There is a sad dissociation between the crucial role that research plays in improving health and the general lack of recognition of its role, importance and priority in public health policies. We tend to forget how much we owe to research once a success story in disease control achieves a happy end. Health authorities and policy makers use to say that they want the real thing -in other words, disease control, now -and not lose time and money with unnecessary and odd expenses -in other terms, health research for tomorrow.
Therefore, I decided to choose as the subject of my lecture a success story in disease control in South America and to point out to the role research has played along its development. It starts at the very beginning -the discovery of the diseaseand goes until the most recent chapter -its elimination as a major public health problem in large regions of the Southern Cone countries. Although no one can yet assure a final "happy end" to this story, progress in its control has been very successful, to the point that the World Health Organization calls it a disease whose days are numbered (Division of Control of Tropical Diseases, 1996) . It is a long story -90 years of history -that illustrates the fundamental importance of research in improving health. By analyzing it, studying the actors, the personalities, the facts, the true or false stories -in other words, the myths -, I think we can derive some universal notions and also some lessons to take home, to keep in mind and put into use when time and opportunity comes.
It is a real story, about Chagas disease -from its discovery in 1909 by the Brazilian scientist Carlos Chagas working at the Oswaldo Cruz Institute in Rio de Janeiro to its successful control in the large regions of the Southern Cone countries in the 90s.
THE INCREDIBLE -AND IMPROBABLE -DISCOVERY
The discovery of American trypanosomiasis by Carlos Chagas has been described and reviewed in a number of publications in Portuguese (Dias 1918 , Aragão 1950 , Da Fonseca filho 1973 , Brener 1989 , Chagas Filho 1993 , Delaporte 1995 , Coura 1997 and English (Guerra 1970 , Lewinsohn 1979 , Wendel & Brener 1992 , Miles 1996 , Perleth 1997 . However, it is only by reading the original articles of Chagas himself [a magnificent collection of all the papers published by Carlos Chagas was organized by Prof. A Prata and published in 1981 by the University of Brasilia (Prata, 1981) ] particularly his classical paper on "Ueber eine neue Trypanosomiasis des Menschen", published in Portuguese and German in the first volume of the Memórias do Instituto Oswaldo Cruz in August, 1909 (Chagas 1909 ) that one can fully apprehend the quality, the extension and the impact of the work of that 29-year old researcher. His genius enabled him to describe the agent, vectors, clinical signs in human beings, animals and the existence of animal reservoirs of a new disease. In this paper, which has superb color plates, Chagas describes the human infection, the parasite (then known as Schizotrypanum cruzi), the cycle in the digestive tract of the invertebrate vector, cultivation in agar-blood and transmission to vertebrates of flagellates from infected triatomines (Wendel & Brener 1992) .
How could one of the major medical discoveries happen in a poor country in the tropics, be published on the first volume of a local institutional journal and yet receive world-wide recognition and be one of the seeds of a whole school of thought and research which still today has such a profound influence in Latin American science?
The roots of this breakthrough have to be analyzed in conjunction with the role played by Oswaldo Cruz and the institution created by the Brazilian Government in 25 May 1900 to fight endemic diseases and which bears his name since • Oswaldo Cruz spent some time at the Pasteur Institute in Paris, and was convinced that the Pasteurian philosophy of combining strategic research, development, production (e.g. of sera and vaccines) and education of young researchers in a single institution would be the key to success; in contemporary words, he was a firm believer in a scientific research system (Stepan 1976);  • by propagating the role that science should play in the development of Brazil, Oswaldo Cruz managed to conquer and receive support from the highest political level (President Rodrigues Alves); being nominated Director of the Federal Department of Public Health, he could efficiently fight the diseases that were devastating Brazil's economy, particularly yellow fever and plague;
• having acquired national leadership, he could mobilize the funds for building up a first-class institution, whose main building -a Moorishstyle palace, based on original drawings by Oswaldo Cruz himself, inspired on the Observatoire Météorologique de Montsouris in Paris -still today attract the curiosity of the lay person, facilitating another of his primary goals: legitimizing the role of science in society;
• very early in the life of the Institute, after his first successes against yellow fever epidemicswhich brought to the Institute the Golden Medal of the XII International Hygiene Conference in Berlin in 1907 -, Oswaldo Cruz could attract the collaboration of scientists from developed countries, particularly from Germany, who would come to visit and work in Rio de Janeiro, interacting with the team of young Brazilian students and researchers recruited to work at the Institute (Gustav Giemsa, Stanislas von Prowazek, Max Hartmann, among others);
• the access to information was always a priority to Oswaldo Cruz; with the funds he could raise, either directly from the government or through the selling of sera and vaccines, he started to build up a very complete biomedical library, acquiring whole collections of contemporary periodicals, some of them dating back to the 18th century. In 1911 the library had already more than 10,000 volumes, making it the largest specialized collection in South America (Stepan 1976 Davies & Mansourian 1992 , Godal et al. 1996 , Raymond 1997 , it is surprising to note how many of the principles and factors underlying today's proposed policies and strategies were already present in a poor country in the beginning of the century. (Kraus et al. 1915 , Kraus & Rosenbusch 1919 . As Chagas had also strong opposition in the Brazilian National Academy of Medicine this episode had a devastating effect and Chagas disease was forgotten for almost 20 years (Wendel & Brener 1992) . According to some researchers Kraus may have been right because Chagas disease would have spread in the Argentine Chaco only some years later (Schofield, pers. comm. and Schofield & Dias 1996) .
Lesson to take home, #1 -
The "resurrection" of Chagas disease is mainly due to the work of Salvador Mazza in Argentina, who described more than a thousand cases particularly in regions which Kraus had studied 20 years before (Mazza 1934 (Mazza , 1936 . Mazza was also the first one to raise the possibility of transfusion-transmitted Chagas disease .
However, it was not until the 80s that countrywide surveys were conducted using standardized protocols and the overall prevalence of human Try-panosoma cruzi infection could be reliably estimated: 18 million cases in 21 endemic countries, with 100 million people -25% of all the inhabitants of Latin America -at risk of infection (Division of Control of Tropical Diseases 1996). The burden of the disease, measured in DALYs and according to data from the World Bank in 1993, showed that in Latin America Chagas disease ranks 1st among the tropical diseases, and 4th among the transmissible diseases, only behind acute respiratory infections, diarrhoeal disease and Aids (Schmunis 1997) .
Why did it take so long to fully disclose the extent of this scourge, if Carlos Chagas in his early papers already called the attention to the social, economic and public health relevance of the disease he had discovered? Was it lack of scientific evidence?
Not so simple, it seems. In this long periodalmost 80 years, from discovery to the large-scale mapping of its prevalence and social impact in the American continent -important information was in fact building up continuously as the result of laboratory, clinical, epidemiological, socioeconomic and applied field research studies. A detailed description of the major findings is again beyond the scope of this lecture. Table I is meant as an initial guide to those interested in further readings. However their results did not translate easily into action. The analysis of the reasons why this did not happen points to the fact that the disease affects mainly poor rural areas that traditionally receive little or no political priority (Dias 1987) , and shows how deep can be the gap among researchers, decision makers, politicians and public interest.
Lesson to take home, #2 -Solid research findings and sound scientific evidence alone, are not sufficient for establishing or imposing political priorities.
TRANSFORMING RESEARCH INTO ACTION, RESEARCHERS INTO POLICY-MAKERS (OR: THE SUCCESSFUL MOBILIZATION TOWARDS CONTROL)
As knowledge about the disease and its prevalence increased, a small group of researchers working at the now legendary Bambuí field station of the Oswaldo Cruz Institute in the State of Minas Gerais, was slowly coming out with the notion that Chagas disease, unlike many other parasitic diseases, could be controlled by eliminating vector populations, chiefly by using insecticides and housing improvements (Dias 1987) .
The crucial experiments were the field trials conducted by Dias and Pellegrino in Brazil and Romaña and Abalos in Argentina in 1947 showing the efficacy of organochlorine insecticides against domiciliated triatomine bugs (Dias & Pellegrino 1948 , Romaña & Abalos 1948 , Schofield 1994 . So good were the results, in fact, that a telegram was sent to the Brazilian Ministry of Health, suggesting that Chagas disease transmission could be eliminated throughout the territory (Dias & Pellegrino 1948 , Pellegrino 1953 , Silveira & Rezende 1994 , Miles 1996 .
Again, was this discovery powerful enough to mobilize the political forces of the nation? Not at all. In spite of the heavy burden of the disease and of the proven availability of appropriate technology for fighting its vectorial transmission, only isolated actions were taken between 1950 and 1975 (Silveira & Rezende 1994 .
All that changed in the 90s, when political decisions at the highest level in six countries established the so-called Southern Cone Initiative -and what we saw in the following years already deserves a special place in history. How and why did that happen? Which were the forces that promoted such a radical change? Which were the major factors responsible for this major shift in priority?
A scientific answer to these questions is surely to be looked for by social scientists, not by a molecular biologist such as myself. Therefore, what follows is just a very personal view of a curious observer and a participating scientist. It may simply be a myth. But as in some cultures a myth is just another way of telling a true story, why not share it with you today?
In 1974 the National Research Council of Brazil (CNPq), which had just started its successful "Integrated Programme on Endemic Diseases" (Programa Integrado de Doenças Endêmicas, PIDE), organized a very small meeting at its headquarters in Rio de Janeiro, with less than ten participants, to discuss some problems in the study of T. cruzi. One important issue of the meeting was the development of a common protocol to cultivate better this parasite in the laboratory. After this was agreed upon, the idea came to organize a second meeting, in one year's time, to evaluate progress made. Prof. Zigman Brener, of the "René Rachou" Regional Research Center of Fiocruz in Belo Horizonte, State of Minas Gerais, was selected by the participants themselves as the organizer of the next meeting.
Owing to the limited CNPq facilities at that time in Rio de Janeiro and also to the fact that the interested participants were working in Rio, São Paulo and Belo Horizonte -and surely because Zigman Brener is from Minas Gerais -the second meeting was arranged to take place in the city of Caxambu, State of Minas Gerais, which is sort of equidistant from those three cities, therefore facilitating travel by car or bus and reducing the costs. In this way the 2nd Annual Meeting on Basic Research on Chagas Disease was organized in November 1975. Although the scientific progress had been solid in (Marshall 1995) and a forum where scientists, research managers, policy makers and government authorities meet and discuss science and public health. From a round table discussion with ten participants, a huge, 700-people annual meeting became established (Table II) .
At the same time, a very important partner came into being and provided much of the grounds needed for international collaboration: I do not hesitate to attribute a pivotal role to TDR in the building up of a critical mass of well trained and informed Latin American scientists interested in Chagas disease.
1984 saw the starting of the Annual Meetings on Applied Research on Chagas Disease, which used to be held in Araxá and now moved to Uberaba, both cities also located in Minas Gerais and at a driving distance from Caxambu, so that one can attend both meetings which take place 1-2 days apart.
These Annual Meetings, in Caxambu and Uberaba, became a major driving force for research in Latin America -and much more. They turned into an annual forum of debates and policy-making. Three examples will illustrate how they helped to transform research into action:
• Sensitizing scientific and public opinion: 1997: an analysis of the cost-effectiveness The study places the program and its (Akhavan 1997 ) and cost-benefit of the Chagas Disease activities in the category of interventions Control Programme conducted by the with a very high cost-effectiveness Ministry of Health of Brazil and PNUD and indicates that it is a health showed that for each US$ 37.30 spent 1 investment with good return; DALY was gained and that for each the study also showed that the decline in dollar spent on prevention almost US$ Chagas disease infection rates was due to 17.50 were saved the preventive activities and not due to general improvement in life conditions 1998: Latin American meeting scheduled (De Andrade et al. 1996 ) to take place in April at Fiocruz headquarters in Rio de Janeiro in order to discuss and adopt a therapeutic protocol to treat young patients in order to prevent the development of chronic cardiac lesions (Dias & Pellegrino 1948) . These data became information in the brain and mouth of the participants -although all the planes were finally bought and no national program started, we all realized that something could be done if we could fight more efficiently towards a higher political priority for public health problems;
• Influencing the government: in 1979 -70 years of the discovery of Chagas disease -it was decided to have the meeting in Rio de Janeiro, to transform it on an international event and to have the President of the Republic at the inauguration ceremony. Prof. Carlos Chagas Filho, the son of Carlos Chagas and himself one of the most highly respected scientists in Brazil, was asked to organize the event. As the result of this strategy, at the end of the meeting funds could be secured for the starting of a pilot vector control programme against Chagas disease;
• Stimulating leadership formation and decision-making: the turning point came years later, when one of our Caxambu fellow scientists, Dr João Carlos Pinto Dias, became the Director of the Chagas Disease Division at the Ministry of Health, when the military regimen ended. The transmutation of researchers into policy-makers, as in his case, opened new perspectives in Chagas disease control and radically changed the priority-setting mechanisms at the Ministry of Health. Finally, research was in action. 
THE NEXT RESEARCH AGENDAS
[For a overview on the trends in Chagas disease research see Moncayo 1994 and Anonymous 1997] .
The "post control" research agenda
We are now at a crossroads in relation to research in Chagas disease, and tension is mounting due to opposing views among researchers, health authorities and policy makers.
On one extreme there are those who think that Chagas disease is well under control, that the existing tools have proven their efficacy and therefore no further effort or resources should be spent in this field. Their arguments seem to be so more valid as the burden of other diseases or unhealthy conditions is skyrocketing in the Third World due to epidemiological and demographic transitions. In fact it is common knowledge that in several developing countries the burden of infectious and parasitic diseases is now being diluted by the toll of chronic and degenerative illnesses, aging and violence and also by emerging and re-emerging diseases, such as Aids (Godal et al. 1996) .
On the other side there are those that insist that the threat from Chagas disease is as serious as it has ever been, that reinfestation of the houses will happen soon in most of the places and that we are in real danger of spoiling all the efforts of the last years by underestimating the adversary.
History has shown us how complex this kind of dilemma can be, and one could pick up whichever example fits better in one's own position, forgetting those that point in the opposite direction. Underestimating the possibility of resurgence of "controlled" diseases can be a fatal mistake (remember tuberculosis control and malaria eradication). On the other hand, several announced apocalypses did not materialize.
I do not think I innovate by saying that one should avoid the extreme scenarios. Although it is true that official data demonstrate the progress made in the control of Chagas disease (Anonymous 1997), particularly in relation to its vectorial transmission which has been virtually eliminated from Brazil (Anonymous 1996) , it is also true that this disease still remains as a scourge in large regions of Latin America (Schmunis 1994) . It is therefore imperative that control programmes against Chagas disease in these areas receive high priority at the local, national and international levels (Schmunis 1997) (Dias 1997) .
Although the persistence of the disease is in part a consequence of this lack of political will to adopt available and proven control tools, e.g. in blood banks, there is undoubtedly the need for a focused, operational research agenda addressing additional key issues related to control activities. (Dias 1997) .This is particularly true for the Andean and Central American countries, where the vectors of Chagas disease are not strictly domiciliary (Division of Control of Tropical Diseases 1996). This research agenda will have to be a rather different one from that of the heroic old times of Lassance, where Chagas disease was discovered, and Bambuí, where the control tools against domiciliated triatomines were first tried. This new agenda will have to focus on nondomiciliated vectors, their systematics, distribution, evolution, genetics, behaviour and population biology (Anonymous 1997). In addition, it should also address topics such as: monitoring of insecticide resistance; diagnostics in areas of low disease prevalence; mathematical modelling and epidemiological impact of control activities (Schofield 1994 , Schofield & Dujardin 1997 .
The unfinished research and development (R&D) agenda
Even if Chagas disease is eliminated as a public health problem from all Latin American countries, we still would have to cope with the problem of millions of chronically-infected people of the region. Recent data indicate that the development of chronic lesions, which seem to be mediated in a large extent by autoimmune mechanisms (Teixeira et al. 1975 , Schmuñis 1987 , Cunha-Neto et al. 1995 , seems to depend on the persistence of parasite infection (Jones et al. 1993 , Higuchi et al. 1993 , Brandariz et al. 1996 , Vago et al. 1996 , Levin 1996 . Therefore the need to find appropriate new drugs, or new protocols with existing drugs, that can be used in the treatment of Chagas disease in order to prevent the development of serious clinical forms (De Andrade et al. 1996 , Urbina et al. 1996 , Luquetti 1997 . As a corollary, one has to define reliable criteria for the cure of these patients, ideally based on the actual determination of parasite load before and after treatment (Britto et al. 1995) .
Another yet unsolved problem in clinical studies on Chagas disease is the question of possible relationships between the different clinical forms, their morbidity and the different parasite strains (Montamat et al. 1996) . The recent demonstration that there are two major phylogenetic lineages of T. cruzi (Souto et al. 1996) will surely stimulate new approaches to this old question (Brener 1973 (Brener , 1977 . In addition, it has brought new perspectives for those interested in molecular epidemiological studies of Chagas disease (Miles et al. 1977 , Mattei et al. 1977 , Morel et al. 1980 , Tibayrenc et al. 1986 , Britto et al. 1995 , Oury et al. 1997 An agenda for the future The ideal strategy against tropical diseases, synthesized in the TDR motto "investigate, eliminate, eradicate", is unfortunately inapplicable to Chagas disease. Due to its zoonotic nature, one can think of elimination of this disease as a public health problem, but eradication of the parasite is not a feasible goal. There is therefore the need for a long-term research agenda for the future, aiming at the development of new prevention and control tools, such as efficient vaccines and safer drugs.
In my vision the road to the future will be strongly based on what is being called the new (molecular) biology, based on the information generated by the various ongoing genome projects, addressing the human, pathogen and vector genomes. Progress in this area has been truly remarkable, with the area now known as "Genomics" evolving from "Structural-" to "Functional-" and "Evolutionary Genomics" (Duboule 1997 ). The results already accumulated are good enough to allow us foresee how biological research will be in the so-called post-genome era (Tilghman 1997) . It is hoped that the T. cruzi genome project will allow a better understanding of the parasite biology and its interaction with the vertebrate and invertebrate hosts, as well as the development of new control tools such as vaccines and therapeutic approaches based on the molecular structure of new targets and rational drug design.
Developing countries are already participating in these efforts, in view of the benefits one can expect from these projects and despite the immense challenges to be faced (Pena 1996 , Zingales et al. 1997a . The T. cruzi genome project, which matured in several meetings in 1993 and 1994 and was officially launched in 1994 in a TDR-Fiocruz co-sponsored meeting held at Fiocruz's headquarters in Rio de Janeiro, is now well under way through the concerted action of more than 20 laboratories, most of them in the South (Cano et al. 1995 , Zingales et al. 1997a ,b,c, Brandão et al. 1997 , Ferrari et al. 1997 , Degrave et al. 1997a .
The research agenda for the future will probably be tackled in a very different way from that used by the founding fathers of Chagas disease research. The new biology -technology intensive and addressing complex problems -has to be carried out through networks and international collaboration, and will have to rely on the newest communication and information technology (Degrave et al. 1997b ).
FINAL COMMENTS
The TDR motto "investigate, eliminate, eradicate" carries in it the notion of different stages of the never-ending fight against diseases. Our microbial enemies and their vectors are smart and able to develop different strategies for coping with our weapons (Garrett 1994 , Anonymous 1994 , Wilson et al. 1994 , Marques 1995 , Schwartz & Bryan 1996 , LeDuc 1996 , Patz et al. 1996 . We have no choice but to be imaginative, flexible and devoid of prejudices in the selection of the new priorities that will shape our next research agendas.
As we move forward in the direction of Chagas disease elimination, entering into a "post-control" era, we will face new and unknown challenges, and the lessons of history will become less and less useful. This brings us to the last lesson to take home:
Lesson to take home, final -After a given point there are no lessons to take home -we will have to rely on further research to shape the road to the future.
In other words, "Caminante, no hay camino, se hace camino al andar" (Antonio Machado, Spanish, 1875 -1939 (1907) (1908) (1909) (1910) (1911) (1912) (1913) (1914) (1915) (1916) (1917) . French translation by Sylvie Léger and Bernard Sesé, Gallimard, 1973. 
